Santen Pharmaceutical Co., Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    €1.73B -0.6% €209.44M +36.1% 12.1% +0.033 pp €390.45M -18.9% 22.5% -0.051 pp
    €1.74B +8.2% €153.90M -278.2% 8.8% +0.14 pp €481.40M +35.0% 27.6% +0.055 pp
    €1.61B +4.8% -€86.35M -154.9% -5.4% -0.16 pp €356.62M -24.6% 22.1% -0.086 pp
    €1.54B +6.7% €157.23M +298.5% 10.2% +0.075 pp €473.02M +30.8% 30.8% +0.057 pp
    €1.44B +3.3% €39.45M -71.1% 2.7% -0.070 pp €361.69M +27.3% 25.1% +0.047 pp
    €1.40B +3.2% €136.43M -26.1% 9.8% -0.039 pp €284.07M +19.3% 20.4% +0.027 pp
    €1.35B +4.0% €184.59M -9.4% 13.7% -0.020 pp €238.15M -21.9% 17.6% -0.058 pp
    €1.30B +13.0% €203.69M +62.3% 15.7% +0.048 pp €304.89M +159.5% 23.5% +0.13 pp
    €1.15B +1.9% €125.49M -59.3% 10.9% -0.16 pp €117.51M -35.7% 10.2% -0.060 pp
    €1.13B +20.7% €308.32M +122.1% 27.3% +0.12 pp €182.64M -65.6% 16.2% -0.41 pp
    €934.84M +8.9% €138.83M +21.9% 14.9% +0.016 pp €530.45M +188.4% 56.7% +0.35 pp
    €858.78M +24.9% €113.90M +19.4% 13.3% -0.0061 pp €183.91M +135.0% 21.4% +0.10 pp
    €687.81M +4.1% €95.43M -3.7% 13.9% -0.011 pp €78.27M -36.9% 11.4% -0.074 pp
    €660.94M +3.3% €99.13M -19.6% 15.0% -0.043 pp €124.10M +20.9% 18.8% +0.027 pp
    €640.12M +0.2% €123.23M +13.9% 19.3% +0.023 pp €102.65M -31.9% 16.0% -0.076 pp
    €638.87M +8.8% €108.15M +84.9% 16.9% +0.070 pp €150.83M +120.4% 23.6% +0.12 pp
    €587.01M -1.7% €58.48M -20.0% 10.0% -0.023 pp €68.45M -23.4% 11.7% -0.033 pp
    €597.27M +2.9% €73.07M -3.8% 12.2% -0.0085 pp €89.35M -16.5% 15.0% -0.035 pp
    €580.47M +2.1% €75.95M +1.0% 13.1% -0.0015 pp €106.95M -19.4% 18.4% -0.049 pp
    €568.41M +6.2% €75.22M +18.1% 13.2% +0.013 pp €132.77M +99.4% 23.4% +0.11 pp
    €535.47M €63.67M 11.9% €66.58M 12.4%

    Notifications